A JPMorgan Chase & Co. Wealth Management sign in New York, U.S., on Thursday, July 10, 2025. Friday, Aug. 1 the “hard deadline” of U.S. President Donald Trump’s updated tariffs is less than two … [+3244 chars]Read More
Eli Lillys obesity pill remains a viable rival to Novos oral Wegovy despite data that…
Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.
